It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
Results from the study should be available by January, Fauci said. If the vaccine proves safe and effective, Fauci said he expects that it could be given to health workers in affected African countries sometime in 2015. "We are starting to discuss some deals with pharmaceutical companies to help scale it up, so on an emergency basis, it might be available in 2015 for health workers who are putting themselves at extreme risk," Fauci said.
There are currently no effective treatments or vaccines for Ebola, which causes fever and headache in early stages but can lead to hemorrhaging, liver failure and kidney failure in later stages. But scientists have been working on four or five preventive vaccines that appear effective
Owensboro, KY - The Defense Advanced Research Projects Agency (DARPA) has announced that Kentucky Bioprocessing (KBP), LLC, is being awarded an agreement for developing a proof-of-concept platform capable of delivering vaccine grade recombinant protein, an essential component of future vaccines.
The platform is a plant based system that uses non-genetically modified tobacco plants as a host for the expression of vaccine grade recombinant protein. The goal of the project is to demonstrate that plant based systems are scalable for rapid delivery of purified recombinant protein that meet all FDA requirements for human use.
Any thoughts ?
originally posted by: dollukka
What i am concerned about is this bio engineering that DARPA is working with, Forbes article of Darpa building its first bio-engineering factory back in 2011
So question is , which do you trust more, big pharmas and their possibly coming vaccine or small company who works hand in hand with DARPA, using non modified tobacco leaves and turning them into GMO vaccines. Darpa has the way to spread this vaccine without your consent...
originally posted by: jjkenobi
a reply to: Snarl
The vaccine is worthless if Ebola only exists in a few poor African countries. If Ebola spreads to first world countries then the vaccine is worth more than gold.
There are currently no effective treatments or vaccines for Ebola, which causes fever and headache in early stages but can lead to hemorrhaging, liver failure and kidney failure in later stages. But scientists have been working on four or five preventive vaccines that appear effective, said Thomas Geisbert, a professor at the University of Texas Medical Branch in Galveston.
Ebola virus has been circulating in the region since at least 2006.
USAMRIID (U.S. Army Medical Research Institute of Infectious Diseases) has been working in the region since 2006, when it began a collaborative project to develop and refine diagnostic tests for the Lassa fever virus endemic to Sierra Leone, Liberia and Guinea. As those assays have matured, the scientists have begun to optimize additional tests for a number of emerging diseases.
Because the team was working on disease identification and diagnostics, and had pre-positioned assays in the region, said Schoepp, “We had people on hand who were already evaluating samples and volunteered to start testing right away when the current Ebola outbreak started.”
The laboratory testing site in Kenema is supported by the Armed Forces Health Surveillance Center-Global Emerging Infections Surveillance and Response System. Other contributors to the work include the Department of Defense Joint Program Executive Office-Critical Reagents Program, the Defense Threat Reduction Agency (DTRA) Cooperative Biological Engagement Program, and the DTRA Joint Science and Technology Office.
USAMRIID’s mission is to protect the warfighter from biological threats.
COL Erin P. Edgar, commander of USAMRIID, called the project “a great example of medical diplomacy at work.”